Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Usana Health Sciences (USNA) Consolidated Net Income (2016 - 2026)

Usana Health Sciences (USNA) has disclosed Consolidated Net Income for 17 consecutive years, with -$1.6 million as the latest value for Q1 2026.

  • Quarterly Consolidated Net Income fell 135.57% to -$1.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $11.5 million through Jan 2026, down 72.71% year-over-year, with the annual reading at $11.5 million for FY2026, 72.71% down from the prior year.
  • Consolidated Net Income for Q1 2026 was -$1.6 million at Usana Health Sciences, up from -$6.7 million in the prior quarter.
  • The five-year high for Consolidated Net Income was $22.8 million in Q4 2022, with the low at -$9.7 million in Q1 2022.
  • Average Consolidated Net Income over 5 years is $11.0 million, with a median of $11.3 million recorded in 2023.
  • The sharpest move saw Consolidated Net Income skyrocketed 333.96% in 2022, then tumbled 162.81% in 2025.
  • Over 5 years, Consolidated Net Income stood at $22.8 million in 2022, then decreased by 26.47% to $16.8 million in 2023, then tumbled by 73.26% to $4.5 million in 2024, then crashed by 248.57% to -$6.7 million in 2025, then soared by 76.06% to -$1.6 million in 2026.
  • According to Business Quant data, Consolidated Net Income over the past three periods came in at -$1.6 million, -$6.7 million, and $10.4 million for Q1 2026, Q3 2025, and Q2 2025 respectively.